Centaur Pharmaceuticals in-licenses Herpes drug Sorivudine from aRigen Pharmaceuticals Japan

30 Jul 2010

1

Mumbai-based Centaur Pharma, India's largest manufacturer and exporter of psychotropic active product ingredients (API), has in-licensed from Japan's aRigen the development and distribution rights for its topical antiviral drug Sorivudine.

The deal enables Centaur to market the product in India and neighbouring countries. Sorivudine is a local application, for Herpes Zoster, which will be introduced for the first time in India, by 2013.

aRigen, incorporated in 2001, is a R&D Japanese biotech company dealing in anti-infective products. aRigen also specialises in anti-bacterials, anti-virals and anti-protozoals.

Centaur now plans to approach the Drugs Controller General India (DCGI) for permission for Phase II and Phase III trials, and marketing rights in India.

Commenting on the deal, Centaur's managing director, S D Sawant, said, ''Our strategy is to ink similar in-licensing agreements with the world's leading drug discovery and development players like aRigen, and derive synergies by leveraging our proficiencies across the pharmaceutical value chain."

Centaur had earlier received the development rights for the new chemical entity (NCE), DPOCL (diperoxochloric acid) solution, for diabetic foot ulcer from Cyto Tools AG, Germany, which the company plans to launch in 2012.

Centaur, established in Mumbai in 1978, owns brands that are leaders in six therapy segments, including the ant-icold segment, with Sinarest.

Latest articles

Technical textiles offer great potential for handloom sector: minister

Technical textiles offer great potential for handloom sector: minister

Nanocoating to improve efficiency of fertilisers

Nanocoating to improve efficiency of fertilisers

IIT Ropar team develops mechanical device for post-surgical knee rehabilitation

IIT Ropar team develops mechanical device for post-surgical knee rehabilitation

Sebi study finds irregularities in royalty payouts by listed Indian companies

Sebi study finds irregularities in royalty payouts by listed Indian companies

Indian business should take part in large numbers in economic events held  in Russia to increase trade

Indian business should take part in large numbers in economic events held  in Russia to increase trade

IBM launches world’s fastest quantum computer, Heron2

IBM launches world’s fastest quantum computer, Heron2

Musk’s Starlink will undermine India’s strategic and technological independence, says think tank

Musk’s Starlink will undermine India’s strategic and technological independence, says think tank

India adds $27.14 bn to its FY25 trade deficit in October to take it to $164.65 bn

India adds $27.14 bn to its FY25 trade deficit in October to take it to $164.65 bn

Indian general insurance sector logs 27.53% growth in Oct. Four insurers log three digit growth

Indian general insurance  sector logs 27.53% growth in Oct. Four insurers log three digit growth

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers